Business Wire Feed
Global e·dentity™ Expands Landmark CRADA with DHS & TSA, Powered by President Trump’s Visionary Leadership to Secure America’s National Identity with Advanced Biometrics
CUPERTINO, Calif.--(BUSINESS WIRE)--Global e·dentity™ Inc., a Delaware-registered Service-Disabled Veteran-Owned Small Business (SDVOSB) and leader in advanced multi-factor biometric identity solutions, today announced a significant amendment (AM01) to its Cooperative Research and Development Agreement (CRADA No. more...
Amadeus Travel Dreams 2026: How AI, Mental Wellbeing, and Sustainability Are Redefining Travel Value
Hoteliers could gain an additional US$1 million through effective retail of six most popular attributes Sustainability-minded travelers willing to pay near 12% premium for the right sustainability credentialsMADRID--(BUSINESS WIRE)--New insights from transformative technology provider, Amadeus, more...
HYROX and Amazfit Strengthen Alliance With Global Three-Year Partnership
The expanded deal between Amazfit and HYROX transforms a successful regional collaboration into a worldwide partnership, supporting the rapid global growth of HYROX and the hybrid training movementMILPITAS, Calif.--(BUSINESS WIRE)--Amazfit, a leading global smart wearable more...
Ziff Davis to Announce First Quarter 2026 Earnings
NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD) will release its First Quarter 2026 Earnings at 6:00PM ET on Thursday, May 7, 2026. Additionally, Ziff Davis invites the public, members of the press, the financial community, more...
USANA Schedules First Quarter 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2026 results will be released after the close of market on Tuesday, May 5, 2026. Shortly following the issuance of the Company’s more...
Atelerix Forms Strategic Partnership With JH Health Ltd to Expand Non-Cryogenic Cell Preservation Capabilities in the Middle East
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region Expands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and more...
Grindr for Equality Launches Out in the Open, A New Series Connecting the LGBTQ+ Community to the Conversations that Matter
Grindr for Equality Presents: Out in the Open with You Are Loved, the first installment focused on chemsexLONDON--(BUSINESS WIRE)--$GRND--Grindr for Equality, the global social impact initiative of Grindr, the world's largest social networking app for more...
QC Kinetix Taps Former The Joint Corp. CEO Peter Holt to Lead Next Phase of National Growth
Experienced health care leader appointed to accelerate growth and strengthen support for clinic ownersCHARLOTTE, N.C.--(BUSINESS WIRE)--QC Kinetix today formally announced the appointment of Peter Holt as chief executive officer, adding a nationally recognized health care more...
New Leadership at DWK Life Sciences: Michael Werth Succeeds Armin Reiche
After serving as CEO for 25 years, Armin Reiche hands operational responsibility to Michael Werth and joins the Advisory Board.WERTHEIM, Germany--(BUSINESS WIRE)--#ceo--DWK Life Sciences, a global leader in precision glassware and primary packaging solutions for more...
WELL Subsidiary CYBERWELL Launches CYDEcore Fusion Platform and Provides Strategic Business Update to Address Escalating Cybersecurity Threats
Consolidated operating model powered by new unified platform, CYDEcore™ Fusion: WELL’s prior cybersecurity assets of Cycura, Seekintoo, and Proack are now integrated into a single cybersecurity organization with centralized leadership, governance, and service delivery. Key more...
Albertsons® Companies Announces National Opioid Settlement Framework
BOISE, Idaho--(BUSINESS WIRE)--Albertsons® Companies, Inc. (NYSE: ACI) today announced it has reached a $774 million settlement framework to resolve substantially all of the opioid-related claims brought against the Company by state, local and tribal government more...
Novigenix AI to Present Clinical Data at AACR 2026 Linking Immuno-Pharmacodynamics to Radioligand Therapy Response
Marks First In-Human Clinical Study Demonstrating the Value of Immuno-Pharmacodynamics in the Assessment of Radioligand Therapy Novigenix AI Liquid Biopsy Platform Identifies Immune Activation Patterns Associated with Radioligand Therapy Response in Gastroenteropancreatic Neuroendocrine Tumors EPALINGES, more...
Sophia Learning Partners with NurseDash to Support Healthcare Career Advancement
HERNDON, Va.--(BUSINESS WIRE)--Sophia Learning, an online, on-demand, self-paced learning platform, announced a partnership with NurseDash, the first on-demand healthcare marketplace for facilities that need staffing support and clinicians looking for open shifts. The collaboration enables more...
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
Collaboration to leverage Q-Plasia OncoReader™ (QPOR™) on routine H&E slides to improve patient selection, accelerate clinical development, and deepen biological understanding of responseNEWTON, Mass.--(BUSINESS WIRE)--#4DPath--4D Path, a company dedicated to personalizing cancer care through a more...
Findings From Long-Term Analysis of the Effects of LYBALVI® (olanzapine and samidorphan) on Negative Symptoms of Schizophrenia Published in The Journal of Clinical Psychiatry
— 56-Week Post Hoc Analysis Demonstrated Sustained Reduction in Hard-to-Treat Negative Symptoms —DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced the publication of a 56-week post hoc analysis of the effects of LYBALVI® (olanzapine and samidorphan) more...
Freed Launches Front Desk, an AI Receptionist That Answers Clinic Calls 24/7
An independent medical practice now has a round-the-clock multilingual receptionist - with pricing starting at $149/month.SAN FRANCISCO--(BUSINESS WIRE)--Freed, the AI clinician assistant trusted by more than 26,000 clinicians and institutions across 100+ specialties, today announced more...
Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training
LONDON & NEW YORK--(BUSINESS WIRE)--$CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for more...
Constellation Kidney Group Expands KidneyOne™, Its Integrated Platform for Kidney Care Providers, with Launch of RCM Intelligence
New analytics capability strengthens the CKG Intelligence data and AI layer powering the KidneyOne platformRICHMOND, Va.--(BUSINESS WIRE)--#Dialysis--April 13, 2026--Constellation Kidney Group (CKG), a leading technology provider for dialysis organizations, today announced the launch of RCM more...
NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
The Company will highlight integrated clinical and genomic insights generated through its Oncology Data Solutions platformFORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced more...
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
Introductions span console electronics, quantitative NMR software, 80 MHz benchtop FT‑NMR, solid‑state and dissolution DNP, and automated protein and RNA workflows.ASILOMAR, Calif.--(BUSINESS WIRE)--$BRKR #BRKR--At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation (Nasdaq: BRKR) more...
Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
Based on results from IDeate-Lung01 Phase 2 trial, with support from IDeate-PanTumor01 Phase 1/2 trial If approved, ifinatamab deruxtecan would be a first-in-class B7-H3 directed DXd antibody drug conjugate for these patients RAHWAY, N.J.--(BUSINESS WIRE)--$MRK more...
Leukogene Therapeutics Announces Two Presentations at the AACR Annual Meeting 2026 Highlighting MHC Class II-Engager Immunotherapies
CHARLESTON, S.C.--(BUSINESS WIRE)--#AML--Leukogene Therapeutics, Inc., an early‑stage oncology company developing MHC class II-engager immunotherapies for immunologically cold cancers, today announced two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 in more...
Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
Oral podium presentation to highlight NeXT Personal® in colorectal cancer; Personalis to debut first data for Real-Time Variant Tracker™ to monitor therapy resistance during NeXT Personal MRD testingFREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader more...
Almirall and Barcelona Supercomputing Center Expand Their Collaboration to Accelerate Innovation in Medical Dermatology
The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High-Performance Computing to identify new opportunities of collaboration in the discovery of new therapies for skin diseases. Almirall joins the ‘BSC Connects’ program more...
PureTech Health: Notice of Results
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2025, on Wednesday, April 29, 2026. more...